Free Trial

Banyan Capital Management Inc. Acquires 16,318 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein logo with Medical background

Banyan Capital Management Inc. lifted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 15.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 119,040 shares of the company's stock after buying an additional 16,318 shares during the period. Henry Schein comprises 4.6% of Banyan Capital Management Inc.'s holdings, making the stock its 13th largest position. Banyan Capital Management Inc. owned approximately 0.10% of Henry Schein worth $8,153,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Whittier Trust Co. raised its holdings in Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after acquiring an additional 700 shares during the period. Dakota Wealth Management raised its holdings in Henry Schein by 34.7% in the 1st quarter. Dakota Wealth Management now owns 17,656 shares of the company's stock valued at $1,209,000 after acquiring an additional 4,551 shares during the period. Edgestream Partners L.P. raised its holdings in Henry Schein by 218.0% in the 1st quarter. Edgestream Partners L.P. now owns 33,301 shares of the company's stock valued at $2,281,000 after acquiring an additional 22,829 shares during the period. MQS Management LLC bought a new position in Henry Schein in the 1st quarter valued at about $502,000. Finally, Allworth Financial LP raised its holdings in Henry Schein by 24.5% in the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock valued at $78,000 after acquiring an additional 232 shares during the period. 96.62% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Evercore ISI increased their price target on shares of Henry Schein from $72.00 to $78.00 and gave the company an "in-line" rating in a report on Wednesday, July 9th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday. Piper Sandler lowered their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, Barrington Research lowered their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Eight investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $78.36.

Read Our Latest Stock Analysis on Henry Schein

Henry Schein Price Performance

Henry Schein stock traded down $0.04 during mid-day trading on Tuesday, reaching $70.64. The company had a trading volume of 4,111,040 shares, compared to its average volume of 1,746,317. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50. The company has a market cap of $8.60 billion, a P/E ratio of 22.08, a P/E/G ratio of 2.28 and a beta of 0.87. The business has a fifty day simple moving average of $71.56 and a 200 day simple moving average of $71.33.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the business posted $1.10 earnings per share. The company's quarterly revenue was down .1% on a year-over-year basis. On average, equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines